Skip to main content
Clinical Trials/CTRI/2020/05/025009
CTRI/2020/05/025009
Completed
Phase 4

To Evaluate the â??Real Worldâ?? CliNicalPerformAnce of the Bisoprolol in Post-myoCardialInfarcTion with Left Ventricular dYsfunction - TENACITY

Dr Kamal Sharma0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: I252- Old myocardial infarction
Sponsor
Dr Kamal Sharma
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Kamal Sharma

Eligibility Criteria

Inclusion Criteria

  • Post MI (NSTEMI \& STEMI) patients with systolic LV dysfunction (HFmEF\&HFrEF i.e. LVEF \< 50%)
  • Patients prescribed with oral Bisoprolol (Concor) during or on discharge from the index hospitalization between 1st August 2016 to 30th November 2018 and follow\-up data for up to 1 year from date of discharge and initiation of treatment under consideration, is available
  • Consent for data collection

Exclusion Criteria

  • Age \<18 at hospitalization
  • Patients with Beta Blocker other than bisoprolol at the index date
  • Patients who leave against medical advice during the hospitalization for MIwith incomplete revascularization.
  • Patients who die during hospitalization for MI
  • Patients presenting with high grade II degree and III degree AV block at the index date (contra\-indication to beta\-blockers)

Outcomes

Primary Outcomes

Not specified

Similar Trials